2006
DOI: 10.1016/j.amjcard.2005.07.129
|View full text |Cite
|
Sign up to set email alerts
|

Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
92
1
10

Year Published

2011
2011
2019
2019

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 135 publications
(110 citation statements)
references
References 18 publications
7
92
1
10
Order By: Relevance
“…Although lack of standardisation and insufficient expertise in performing cardiopulmonary exercise testing were identified as the main reasons explaining this discrepancy [81], the 6-MWT remains until now the only Food and Drug Administration-and European Agency for the Evaluation of Medicinal Productsaccepted exercise end-point for studies evaluating treatment effects in PAH. Despite detailed recommendations [84,85], a generally accepted standardisation of cardiopulmonary exercise testing with respect to data acquisition and analysis in PAH is lacking.…”
Section: Exercise Capacitymentioning
confidence: 99%
See 1 more Smart Citation
“…Although lack of standardisation and insufficient expertise in performing cardiopulmonary exercise testing were identified as the main reasons explaining this discrepancy [81], the 6-MWT remains until now the only Food and Drug Administration-and European Agency for the Evaluation of Medicinal Productsaccepted exercise end-point for studies evaluating treatment effects in PAH. Despite detailed recommendations [84,85], a generally accepted standardisation of cardiopulmonary exercise testing with respect to data acquisition and analysis in PAH is lacking.…”
Section: Exercise Capacitymentioning
confidence: 99%
“…In PAH, O 2 uptake at the anaerobic threshold and peak exercise are reduced in relation to disease severity, as are peak work rate, peak heart rate, O 2 pulse and ventilatory efficiency [81]. Following multivariate analysis of clinical, haemodynamic and exercise parameters peak O 2 uptake (,10.4 mL O 2 ?kg -1 ?min -1 ) and peak systolic arterial pressure during exercise (,120 mmHg) independently predicted a worse prognosis in IPAH patients [75].…”
Section: Exercise Capacitymentioning
confidence: 99%
“…2 In addition, the 6MWT is a significant predictor of survival in patients with pulmonary hypertension [7][8][9][10][11] and is used in clinical trials for IPAH medications. 12 In addition to other health limiting and debilitating conditions, patients with lung or heart disease may show a reduced 6-minute walk distance (6MWD).…”
Section: Doi: 101097/hcr0000000000000174mentioning
confidence: 99%
“…Peak V o 2 , measured by a CPET, has been widely used to assess functional capacity and predict survival in patients with advanced symptomatic heart failure and respiratory dysfunction. 1,2 However, CPET requires the use of expensive equipment and trained medical team supervision to conduct and evaluate each test.…”
mentioning
confidence: 99%
“…Untreated exercise ischemia can lead to inadequate supply of blood flow, or lack of oxygenation of the myocardium which in turn may lead to infarction and irreversible localize death of the heart tissue, as well as other heart conditions. Peak Oxygen Uptake (pVO₂), measured via CPET, has been widely used to assess functional capacity and predict survival in diseased populations such those with advanced symptomatic heart failure (Cahalin, Mathier, Semigran, Dec, & DiSalvo, 1996;Oudiz et al, 2006). Pulmonary vascular resistance was found to increase as pVO₂ (measured by CPET) and Cardiac Output, or volume of blood pumped by the heart per unit time (CO), decreased in patients with heart failure (Butler, Chomsky, & Wilson, 1999).…”
Section: 141clinical Exercise Testing In Heart Diseasementioning
confidence: 99%